MedPath
TGA Approval

SCEMBLIX asciminib (as hydrochloride) 20 mg film-coated tablet blister pack (371019)

371019

SCEMBLIX asciminib (as hydrochloride) 20 mg film-coated tablet blister pack

Novartis Pharmaceuticals Australia Pty Ltd

July 15, 2022

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/6dc0b9305193900a9856870057f7fd34.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/fce5054de19e5e97ec5d0591c2ae16cd.pdf

Active Ingredients

asciminib hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.